Delivery Order SPE2DX15D8002-SPE2DX24F2WL7
Award Date
5/28/24
Potential Completion Date
5/29/24
Potential Value
$16K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,867.25 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,274.15 firm fixed-price delivery order is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a period of performance through February 1, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, as part of the ECAT Generation V Program, which allows the...
This federal contract award, valued at $11,442.51, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period extending through June 12, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The...
The Defense Logistics Agency (DLA) awarded a $8,232.42 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML. This order was placed under Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which supports the agency's ECAT Generation V Program for procuring commercial medical equipment, accessories, consumables, and simulation equipment. The contract has an...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTLE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $1,867.25. The contract is a Firm Fixed Price Delivery Order with a performance period ending on December 12, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business registered in the System for Award...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,722.06 Firm Fixed Price Delivery Order contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has an ultimate completion date of February 5, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB24FJMVF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract, valued at $5,405.43, is a firm fixed-price delivery order for the provision of Dupixent 300 mg/2 ml syringes. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. As a prime contractor to the DLA Troop Support Medical, the company plays a crucial role...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,627.95 contract is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of the DLA Troop Support Medical's mission to provide comprehensive medical supply chain operations for the U.S. Armed Forces. Dakota Drug, Inc. has a long history of serving as a prime...
This federal contract award SPE2DX15D8003|SPE2DX24F7D9E was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The firm-fixed-price contract has a ceiling value of $5,788.47 and an ultimate completion date of May 24, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,049.12 firm fixed-price delivery order contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML medical products. This award is part of Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, under the ECAT Generation V Program. The contract has a period of...